These data suggest that co-inhibition of the PI3K/AKT pathway and ERK pathway in pancreatic tumor cells effectively suppresses tumor growth in PI3K/AKT pathway-activated pancreatic tumor cells. Here, AKT1 is linked to neoplasm.